What's on the web on your pursuit, hobbies, interests and worries

HemophiliaA news

First Hemophilia A Patient Enrolls in Phase 4 Trial for Eloctate Immune Tolerance Induction

Hemophilia News Today - Nov 13, 2017
Researchers will investigate the ability of Eloctate (efmoroctocog alfa), a recombinant clotting factor therapy developed for hemophilia A, to induce immune tolerance, a process scientists describe as immune tolerance induction (ITI) potential, for up ...

Interim Data Show Improvements in Hemophilia A Patients with Eloctate

Rare Disease Report (blog) - Oct 31, 2017
Results were released last night from a longitudinal study of joint health in patients with Hemophilia A treated prophylactically with Eloctate [Antihemophilic Factor (Recombinant), Fc Fusion Protein], marketed as Elocta in Europe and the Middle East.

FDA Accepts Bayer Application for BAY94-9027 to Possibly Treat Hemophilia A

Hemophilia News Today - Nov 3, 2017
The U.S. Food and Drug Administration (FDA) has accepted Bayer's Biologics License Application (BLA) filing for BAY94-9027 to treat hemophilia A in adolescents starting at age 12, and in adults. A BLA is a marketing application that covers biological ...

Hemophilia A - premium items on eBay

Hemophilia: A Study in Hope & Reality by Alfred Katz (1970,HC,DJ)


Survivor: One Mans Battle with HIV, Hemophilia, a




>> Go to all great Hemophilia A deals on eBay

Hemophilia A pictures on the web

>> Show

Hemophilia A videos

Factor VIII and Hemophilia A

Donate here: http://www.aklectures.com/donate.php Website video link: http://www.aklectures.com/lecture/factor-viii-and-hemophilia-a Facebook link: ...

Hemophilia A & B

WVNCC Nursing concepts of health and illness 2.

A Novel Hemophilia A Therapy

Severe hemophilia A is often treated with infusions of factor VIII. But the infusions are burdensome, and antibodies develop in about 30% of patients.

Hemophilia a educational video

Hemophilia a educational video.

Assessing Recent Advances in Hemophilia A Management

Course Director, Guy Young, MD, discusses hemophilia A management in this CME/CE activity titled \